EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis

Xia Niu, Shuyu Zhang, Chen Shao, Zhengguang Guo, Jianqiang Wu iD, Jianling Tao, Ke Zheng, Wenling Ye, Guangyan Cai, Wei Sun, Mingxi Li iD

PeerJ · 11.04.2023 · 11 · e15125

DOI: 10.7717/peerj.15125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, online erschienen am 11.04.2023. Verfasst von Xia Niu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Core Facility of Instruments, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medica…. Hauptthemen laut MEDLINE: Glomerulonephritis, IGA, Glomerulonephritis, Membranous. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Municipal Science and Technology Project, Youth Fund of Peking Union Medical College Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

IgA nephropathy (IgAN) is one of the leading causes of end-stage renal disease (ESRD). Urine testing is a non-invasive way to track the biomarkers used for measuring renal injury. This study aimed to analyse urinary complement proteins during IgAN progression using quantitative proteomics.

Methods

In the discovery phase, we analysed 22 IgAN patients who were divided into three groups (IgAN 1-3) according to their estimated glomerular filtration rate (eGFR). Eight patients with primary membranous nephropathy (pMN) were used as controls. Isobaric tags for relative and absolute quantitation (iTRAQ) labelling, coupled with liquid chromatography-tandem mass spectrometry, was used to analyse global urinary protein expression. In the validation phase, western blotting and parallel reaction monitoring (PRM) were used to verify the iTRAQ results in an independent cohort ( N = 64).

Results

In the discovery phase, 747 proteins were identified in the urine of IgAN and pMN patients. There were different urine protein profiles in IgAN and pMN patients, and the bioinformatics analysis revealed that the complement and coagulation pathways were most activated. We identified a total of 27 urinary complement proteins related to IgAN. The relative abundance of C3, the membrane attack complex (MAC), the complement regulatory proteins of the alternative pathway (AP), and MBL (mannose-binding lectin) and MASP1 (MBL associated serine protease 2) in the lectin pathway (LP) increased during IgAN progression. This was especially true for MAC, which was found to be involved prominently in disease progression. Alpha-N-acetylglucosaminidase (NAGLU) and α-galactosidase A (GLA) were validated by western blot and the results were consistent with the iTRAQ results. Ten proteins were validated in a PRM analysis, and these results were also consistent with the iTRAQ results. Complement factor B (CFB) and complement component C8 alpha chain (C8A) both increased with the progression of IgAN. The combination of CFB and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) also showed potential as a urinary biomarker for monitoring IgAN development.

Conclusion

There were abundant complement components in the urine of IgAN patients, indicating that the activation of AP and LP is involved in IgAN progression. Urinary complement proteins may be used as biomarkers for evaluating IgAN progression in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulonephritis, IGAGlomerulonephritis, MembranousHumansProteomicsKidneyComplement System ProteinsBiomarkersComplement Membrane Attack ComplexLectins

Stichwörter der Autor:innen

Complement proteinsIgA nephropathyProteomicsUrineα-N-acetylglucosaminidase

Substanzen

Complement System ProteinsBiomarkersComplement Membrane Attack ComplexLectins

Autor:innen und Institutionen

  • Core Facility of Instruments, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, China.
  • Department of Nephrology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Nephrology, The First Medical Centre, Chinese PLA General Hospital, Medical School of Chinese PLA, Beijing, China.

ORCID-Profile: Jianqiang Wu, Mingxi Li

Förderung

  • National Natural Science Foundation of China
  • Beijing Municipal Science and Technology Project
  • Youth Fund of Peking Union Medical College Hospital

Zitieren

APA

Niu, X., Zhang, S., Shao, C., Guo, Z., Wu, J., Tao, J., Zheng, K., Ye, W., Cai, G., Sun, W., & Li, M. (2023). Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis. PeerJ, 11, e15125. https://doi.org/10.7717/peerj.15125

Vancouver

Niu X, Zhang S, Shao C, Guo Z, Wu J, Tao J, et al. Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis. PeerJ. 2023;11:e15125. doi:10.7717/peerj.15125

BibTeX
@article{Niu2023,
  author = {Niu, Xia and Zhang, Shuyu and Shao, Chen and Guo, Zhengguang and Wu, Jianqiang and Tao, Jianling and Zheng, Ke and Ye, Wenling and Cai, Guangyan and Sun, Wei and Li, Mingxi},
  title = {Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis},
  journal = {PeerJ},
  year = {2023},
  volume = {11},
  pages = {e15125},
  doi = {10.7717/peerj.15125}
}
Kostenlos starten →